Industry Research Reports
Home > Reports > Chemical & Material > Global Cycloastragenol Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Cycloastragenol Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-25
Pages: 140 Pages
Report ld: 5263067
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cycloastragenol Market Size(US$)
CAGR 2025-2031
3.3%
Market Size,2031
USD 118
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 97 million
Market Forecast in 2031(Value)
US$ 118 million
CAGR
3.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cycloastragenol market is projected to grow from US$ 94.4 million in 2024 to US$ 118 million by 2031, at a CAGR of 3.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Cycloastragenol extract from astragalus Root.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Cycloastragenol market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- NandR Bio Industries
- Bio-norm
- Xi'an Huisun Bio-Tech
- Shaanxi Pioneer Biotech
- Simagchem
- Xi'an Lyphar Biotech
- Xi'an SR Bio-Engineering
- Changsha Comext Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Powder
- Capsule
- Others
Segment by Application
- Pharma and Healthcare
- Food Additives
- Cosmetic and Skin Care
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Cycloastragenol study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cycloastragenol: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cycloastragenol Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Powder
1.2.3 Capsule
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Cycloastragenol Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharma and Healthcare
1.3.3 Food Additives
1.3.4 Cosmetic and Skin Care
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cycloastragenol Revenue Estimates and Forecasts 2020-2031
2.2 Global Cycloastragenol Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Cycloastragenol Sales Estimates and Forecasts 2020-2031
2.4 Global Cycloastragenol Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Cycloastragenol Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Cycloastragenol Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Cycloastragenol Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Powder Market Size by Manufacturers
4.5.2 Capsule Market Size by Manufacturers
4.5.3 Others Market Size by Manufacturers
4.6 Global Cycloastragenol Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Cycloastragenol Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Cycloastragenol Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Cycloastragenol Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Cycloastragenol Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Cycloastragenol Sales and Revenue by Type (2020-2031)
7.4 North America Cycloastragenol Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Cycloastragenol Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Cycloastragenol Sales and Revenue by Type (2020-2031)
8.4 Europe Cycloastragenol Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Cycloastragenol Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Cycloastragenol Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Cycloastragenol Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Cycloastragenol Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Cycloastragenol Sales and Revenue by Type (2020-2031)
10.4 Central and South America Cycloastragenol Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Cycloastragenol Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Cycloastragenol Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Cycloastragenol Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Cycloastragenol Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 NandR Bio Industries
12.1.1 NandR Bio Industries Corporation Information
12.1.2 NandR Bio Industries Business Overview
12.1.3 NandR Bio Industries Cycloastragenol Product Models, Descriptions and Specifications
12.1.4 NandR Bio Industries Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 NandR Bio Industries Cycloastragenol Sales by Product in 2024
12.1.6 NandR Bio Industries Cycloastragenol Sales by Application in 2024
12.1.7 NandR Bio Industries Cycloastragenol Sales by Geographic Area in 2024
12.1.8 NandR Bio Industries Cycloastragenol SWOT Analysis
12.1.9 NandR Bio Industries Recent Developments
12.2 Bio-norm
12.2.1 Bio-norm Corporation Information
12.2.2 Bio-norm Business Overview
12.2.3 Bio-norm Cycloastragenol Product Models, Descriptions and Specifications
12.2.4 Bio-norm Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Bio-norm Cycloastragenol Sales by Product in 2024
12.2.6 Bio-norm Cycloastragenol Sales by Application in 2024
12.2.7 Bio-norm Cycloastragenol Sales by Geographic Area in 2024
12.2.8 Bio-norm Cycloastragenol SWOT Analysis
12.2.9 Bio-norm Recent Developments
12.3 Xi'an Huisun Bio-Tech
12.3.1 Xi'an Huisun Bio-Tech Corporation Information
12.3.2 Xi'an Huisun Bio-Tech Business Overview
12.3.3 Xi'an Huisun Bio-Tech Cycloastragenol Product Models, Descriptions and Specifications
12.3.4 Xi'an Huisun Bio-Tech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Xi'an Huisun Bio-Tech Cycloastragenol Sales by Product in 2024
12.3.6 Xi'an Huisun Bio-Tech Cycloastragenol Sales by Application in 2024
12.3.7 Xi'an Huisun Bio-Tech Cycloastragenol Sales by Geographic Area in 2024
12.3.8 Xi'an Huisun Bio-Tech Cycloastragenol SWOT Analysis
12.3.9 Xi'an Huisun Bio-Tech Recent Developments
12.4 Shaanxi Pioneer Biotech
12.4.1 Shaanxi Pioneer Biotech Corporation Information
12.4.2 Shaanxi Pioneer Biotech Business Overview
12.4.3 Shaanxi Pioneer Biotech Cycloastragenol Product Models, Descriptions and Specifications
12.4.4 Shaanxi Pioneer Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Shaanxi Pioneer Biotech Cycloastragenol Sales by Product in 2024
12.4.6 Shaanxi Pioneer Biotech Cycloastragenol Sales by Application in 2024
12.4.7 Shaanxi Pioneer Biotech Cycloastragenol Sales by Geographic Area in 2024
12.4.8 Shaanxi Pioneer Biotech Cycloastragenol SWOT Analysis
12.4.9 Shaanxi Pioneer Biotech Recent Developments
12.5 Simagchem
12.5.1 Simagchem Corporation Information
12.5.2 Simagchem Business Overview
12.5.3 Simagchem Cycloastragenol Product Models, Descriptions and Specifications
12.5.4 Simagchem Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Simagchem Cycloastragenol Sales by Product in 2024
12.5.6 Simagchem Cycloastragenol Sales by Application in 2024
12.5.7 Simagchem Cycloastragenol Sales by Geographic Area in 2024
12.5.8 Simagchem Cycloastragenol SWOT Analysis
12.5.9 Simagchem Recent Developments
12.6 Xi'an Lyphar Biotech
12.6.1 Xi'an Lyphar Biotech Corporation Information
12.6.2 Xi'an Lyphar Biotech Business Overview
12.6.3 Xi'an Lyphar Biotech Cycloastragenol Product Models, Descriptions and Specifications
12.6.4 Xi'an Lyphar Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Xi'an Lyphar Biotech Recent Developments
12.7 Xi'an SR Bio-Engineering
12.7.1 Xi'an SR Bio-Engineering Corporation Information
12.7.2 Xi'an SR Bio-Engineering Business Overview
12.7.3 Xi'an SR Bio-Engineering Cycloastragenol Product Models, Descriptions and Specifications
12.7.4 Xi'an SR Bio-Engineering Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Xi'an SR Bio-Engineering Recent Developments
12.8 Changsha Comext Biotech
12.8.1 Changsha Comext Biotech Corporation Information
12.8.2 Changsha Comext Biotech Business Overview
12.8.3 Changsha Comext Biotech Cycloastragenol Product Models, Descriptions and Specifications
12.8.4 Changsha Comext Biotech Cycloastragenol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Changsha Comext Biotech Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Cycloastragenol Industry Chain
13.2 Cycloastragenol Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Cycloastragenol Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Cycloastragenol Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Cycloastragenol Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Cycloastragenol Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cycloastragenol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cycloastragenol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cycloastragenol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cycloastragenol Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cycloastragenol Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cycloastragenol Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Cycloastragenol Sales by Region (2020-2025) & (MT)
Table 8. Global Cycloastragenol Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cycloastragenol Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Cycloastragenol Production by Region (2020-2025) & (MT)
Table 12. Global Cycloastragenol Production by Region (2026-2031) & (MT)
Table 13. Global Cycloastragenol Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Cycloastragenol Sales Share by Manufacturers (2020-2025)
Table 15. Global Cycloastragenol Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Cycloastragenol Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Cycloastragenol by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cycloastragenol as of 2024)
Table 19. Global Cycloastragenol Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Cycloastragenol Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Cycloastragenol Manufacturing Base and Headquarters
Table 22. Global Cycloastragenol Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Cycloastragenol Sales by Type (2020-2025) & (MT)
Table 26. Global Cycloastragenol Sales by Type (2026-2031) & (MT)
Table 27. Global Cycloastragenol Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Cycloastragenol Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Cycloastragenol ASP by Type (2020-2031) & (USD/Kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Cycloastragenol Sales by Application (2020-2025) & (MT)
Table 32. Global Cycloastragenol Sales by Application (2026-2031) & (MT)
Table 33. Cycloastragenol High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Cycloastragenol Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Cycloastragenol Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Cycloastragenol ASP by Application (2020-2031) & (USD/Kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Cycloastragenol Growth Accelerators and Market Barriers
Table 40. North America Cycloastragenol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Cycloastragenol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Cycloastragenol Growth Accelerators and Market Barriers
Table 43. Europe Cycloastragenol Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Cycloastragenol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Cycloastragenol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Cycloastragenol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Cycloastragenol Growth Accelerators and Market Barriers
Table 48. Southeast Asia Cycloastragenol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Cycloastragenol Investment Opportunities and Key Challenges
Table 50. Central and South America Cycloastragenol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Cycloastragenol Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Cycloastragenol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. NandR Bio Industries Corporation Information
Table 54. NandR Bio Industries Description and Major Businesses
Table 55. NandR Bio Industries Product Models, Descriptions and Specifications
Table 56. NandR Bio Industries Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 57. NandR Bio Industries Sales Value Proportion by Product in 2024
Table 58. NandR Bio Industries Sales Value Proportion by Application in 2024
Table 59. NandR Bio Industries Sales Value Proportion by Geographic Area in 2024
Table 60. NandR Bio Industries Cycloastragenol SWOT Analysis
Table 61. NandR Bio Industries Recent Developments
Table 62. Bio-norm Corporation Information
Table 63. Bio-norm Description and Major Businesses
Table 64. Bio-norm Product Models, Descriptions and Specifications
Table 65. Bio-norm Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 66. Bio-norm Sales Value Proportion by Product in 2024
Table 67. Bio-norm Sales Value Proportion by Application in 2024
Table 68. Bio-norm Sales Value Proportion by Geographic Area in 2024
Table 69. Bio-norm Cycloastragenol SWOT Analysis
Table 70. Bio-norm Recent Developments
Table 71. Xi'an Huisun Bio-Tech Corporation Information
Table 72. Xi'an Huisun Bio-Tech Description and Major Businesses
Table 73. Xi'an Huisun Bio-Tech Product Models, Descriptions and Specifications
Table 74. Xi'an Huisun Bio-Tech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Xi'an Huisun Bio-Tech Sales Value Proportion by Product in 2024
Table 76. Xi'an Huisun Bio-Tech Sales Value Proportion by Application in 2024
Table 77. Xi'an Huisun Bio-Tech Sales Value Proportion by Geographic Area in 2024
Table 78. Xi'an Huisun Bio-Tech Cycloastragenol SWOT Analysis
Table 79. Xi'an Huisun Bio-Tech Recent Developments
Table 80. Shaanxi Pioneer Biotech Corporation Information
Table 81. Shaanxi Pioneer Biotech Description and Major Businesses
Table 82. Shaanxi Pioneer Biotech Product Models, Descriptions and Specifications
Table 83. Shaanxi Pioneer Biotech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 84. Shaanxi Pioneer Biotech Sales Value Proportion by Product in 2024
Table 85. Shaanxi Pioneer Biotech Sales Value Proportion by Application in 2024
Table 86. Shaanxi Pioneer Biotech Sales Value Proportion by Geographic Area in 2024
Table 87. Shaanxi Pioneer Biotech Cycloastragenol SWOT Analysis
Table 88. Shaanxi Pioneer Biotech Recent Developments
Table 89. Simagchem Corporation Information
Table 90. Simagchem Description and Major Businesses
Table 91. Simagchem Product Models, Descriptions and Specifications
Table 92. Simagchem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Simagchem Sales Value Proportion by Product in 2024
Table 94. Simagchem Sales Value Proportion by Application in 2024
Table 95. Simagchem Sales Value Proportion by Geographic Area in 2024
Table 96. Simagchem Cycloastragenol SWOT Analysis
Table 97. Simagchem Recent Developments
Table 98. Xi'an Lyphar Biotech Corporation Information
Table 99. Xi'an Lyphar Biotech Description and Major Businesses
Table 100. Xi'an Lyphar Biotech Product Models, Descriptions and Specifications
Table 101. Xi'an Lyphar Biotech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 102. Xi'an Lyphar Biotech Recent Developments
Table 103. Xi'an SR Bio-Engineering Corporation Information
Table 104. Xi'an SR Bio-Engineering Description and Major Businesses
Table 105. Xi'an SR Bio-Engineering Product Models, Descriptions and Specifications
Table 106. Xi'an SR Bio-Engineering Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 107. Xi'an SR Bio-Engineering Recent Developments
Table 108. Changsha Comext Biotech Corporation Information
Table 109. Changsha Comext Biotech Description and Major Businesses
Table 110. Changsha Comext Biotech Product Models, Descriptions and Specifications
Table 111. Changsha Comext Biotech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 112. Changsha Comext Biotech Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Cycloastragenol Product Picture
Figure 2. Global Cycloastragenol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Powder Product Picture
Figure 4. Capsule Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cycloastragenol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharma and Healthcare
Figure 8. Food Additives
Figure 9. Cosmetic and Skin Care
Figure 10. Others
Figure 11. Cycloastragenol Report Years Considered
Figure 12. Global Cycloastragenol Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 14. Global Cycloastragenol Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Cycloastragenol Revenue Market Share by Region (2020-2031)
Figure 16. Global Cycloastragenol Sales (2020-2031) & (MT)
Figure 17. Global Cycloastragenol Sales (CAGR) by Region (2020-2031) (MT)
Figure 18. Global Cycloastragenol Sales Market Share by Region (2020-2031)
Figure 19. Global Cycloastragenol Capacity, Production and Utilization (2020-2031) & (MT)
Figure 20. Global Cycloastragenol Production Trend by Region (2020-2031) (MT)
Figure 21. Global Cycloastragenol Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Cycloastragenol Production Growth Rate in North America (2020-2031) & (MT)
Figure 24. Cycloastragenol Production Growth Rate in Europe (2020-2031) & (MT)
Figure 25. Cycloastragenol Production Growth Rate in China (2020-2031) & (MT)
Figure 26. Cycloastragenol Production Growth Rate in Japan (2020-2031) & (MT)
Figure 27. Top 5 and Top 10 Manufacturers Cycloastragenol Sales Volume Market Share in 2024
Figure 28. Global Cycloastragenol Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. Powder Revenue Market Share by Manufacturer in 2024
Figure 31. Capsule Revenue Market Share by Manufacturer in 2024
Figure 32. Others Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global Cycloastragenol Sales Market Share by Type (2020-2031)
Figure 36. Global Cycloastragenol Revenue Market Share by Type (2020-2031)
Figure 37. Global Cycloastragenol Sales Market Share by Application (2020-2031)
Figure 38. Global Cycloastragenol Revenue Market Share by Application (2020-2031)
Figure 39. North America Cycloastragenol Sales YoY (2020-2031) & (MT)
Figure 40. North America Cycloastragenol Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers Cycloastragenol Sales Revenue (US$ Million) in 2024
Figure 42. North America Cycloastragenol Sales Volume (MT) by Type (2020- 2031)
Figure 43. North America Cycloastragenol Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America Cycloastragenol Sales Volume (MT) by Application (2020-2031)
Figure 45. North America Cycloastragenol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 47. Canada Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 49. Europe Cycloastragenol Sales YoY (2020-2031) & (MT)
Figure 50. Europe Cycloastragenol Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers Cycloastragenol Sales Revenue (US$ Million) in 2024
Figure 52. Europe Cycloastragenol Sales Volume (MT) by Type (2020-2031)
Figure 53. Europe Cycloastragenol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe Cycloastragenol Sales Volume (MT) by Application (2020-2031)
Figure 55. Europe Cycloastragenol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 57. France Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 59. Italy Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 60. Russia Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Cycloastragenol Sales YoY (2020-2031) & (MT)
Figure 62. Asia-Pacific Cycloastragenol Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers Cycloastragenol Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific Cycloastragenol Sales Volume (MT) by Type (2020- 2031)
Figure 65. Asia-Pacific Cycloastragenol Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific Cycloastragenol Sales Volume (MT) by Application (2020-2031)
Figure 67. Asia-Pacific Cycloastragenol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 69. Japan Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 72. India Cycloastragenol Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America Cycloastragenol Sales YoY (2020-2031) & (MT)
Figure 74. Central and South America Cycloastragenol Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers Cycloastragenol Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America Cycloastragenol Sales Volume (MT) by Type (2021-2031)
Figure 77. Central and South America Cycloastragenol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America Cycloastragenol Sales Volume (MT) by Application (2020-2031)
Figure 79. Central and South America Cycloastragenol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa Cycloastragenol Sales YoY (2020-2031) & (MT)
Figure 83. Middle East and Africa Cycloastragenol Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers Cycloastragenol Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa Cycloastragenol Sales Volume (MT) by Type (2021-2031)
Figure 86. South America Cycloastragenol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa Cycloastragenol Sales Volume (MT) by Application (2020-2031)
Figure 88. Middle East and Africa Cycloastragenol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa Cycloastragenol Revenue (2020-2025) & (US$ Million)
Figure 93. Cycloastragenol Industry Chain Mapping
Figure 94. Regional Cycloastragenol Manufacturing Base Distribution (%)
Figure 95. Cycloastragenol Production Process
Figure 96. Regional Cycloastragenol Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Cycloastragenol in 2031?
The global market size of Cycloastragenol in 2031 was 118 Million USD.
Which companies rank high in the global Cycloastragenol market?
Which region is expected to have the highest market share?
What was the global market size of Cycloastragenol in 2025?
What is the annual compound growth rate of the global Cycloastragenol market size from 2025 to 2031?
Related Reports
Cycloastragenol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cycloastragenol was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 122 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 126
USD 3950.00
(Single User License)
Global Cycloastragenol Market Research Report 2026
The global Cycloastragenol market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 122 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published Date: 2026-04-25
Pages: 131
USD 2900.00
(Single User License)
Global Cycloastragenol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cycloastragenol market size was US$ 94.4 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 77
USD 4250.00
(Single User License)
Global Cycloastragenol Market Research Report 2025
The global market for Cycloastragenol was valued at US$ 94.4 million in the year 2024 and is projected to reach a revised size of US$ 118 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published Date: 2025-02-21
Pages: 87
USD 2900.00
(Single User License)
Cycloastragenol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cycloastragenol was estimated to be worth US$ 94.4 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 103
USD 3950.00
(Single User License)
Global Cycloastragenol Market Insights, Forecast to 2030
Cycloastragenol extract from astragalus Root.
Published Date: 2024-04-07
Pages: 92
USD 4900.00
(Single User License)
Global Cycloastragenol Market Research Report 2024
Cycloastragenol extract from astragalus Root.
Published Date: 2024-01-10
Pages: 87
USD 2900.00
(Single User License)
Cycloastragenol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cycloastragenol was estimated to be worth US$ 97 million in 2025 and is projected to reach US$ 122 million, growing at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-07-09
Pages: 126
USD 3950.00 (Single User License)Global Cycloastragenol Market Research Report 2026
The global Cycloastragenol market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 122 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
Published: 2026-04-25
Pages: 131
USD 2900.00 (Single User License)Global Cycloastragenol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cycloastragenol market size was US$ 94.4 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 77
USD 4250.00 (Single User License)Global Cycloastragenol Market Research Report 2025
The global market for Cycloastragenol was valued at US$ 94.4 million in the year 2024 and is projected to reach a revised size of US$ 118 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Published: 2025-02-21
Pages: 87
USD 2900.00 (Single User License)Cycloastragenol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cycloastragenol was estimated to be worth US$ 94.4 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 103
USD 3950.00 (Single User License)Global Cycloastragenol Market Insights, Forecast to 2030
Cycloastragenol extract from astragalus Root.
Published: 2024-04-07
Pages: 92
USD 4900.00 (Single User License)Global Cycloastragenol Market Research Report 2024
Cycloastragenol extract from astragalus Root.
Published: 2024-01-10
Pages: 87
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now